APA

Egbuna O. I., Davis R. B., Chudinski R., Pavlakis M., Rogers C., Molakatalla P., Johnson S. R., Karp S., Monaco A. P., Tang H., Hanto D. W. & Mandelbrot D. A. (20090928). Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. : Transplantation.

Chicago

Egbuna Ogo I, Davis Roger B, Chudinski Robyn, Pavlakis Martha, Rogers Christin, Molakatalla Phani, Johnson Scott R, Karp Seth, Monaco Anthony P, Tang Hongying, Hanto Douglas W and Mandelbrot Didier A. 20090928. Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. : Transplantation.

Harvard

Egbuna O. I., Davis R. B., Chudinski R., Pavlakis M., Rogers C., Molakatalla P., Johnson S. R., Karp S., Monaco A. P., Tang H., Hanto D. W. and Mandelbrot D. A. (20090928). Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. : Transplantation.

MLA

Egbuna Ogo I, Davis Roger B, Chudinski Robyn, Pavlakis Martha, Rogers Christin, Molakatalla Phani, Johnson Scott R, Karp Seth, Monaco Anthony P, Tang Hongying, Hanto Douglas W and Mandelbrot Didier A. Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. : Transplantation. 20090928.